The inflammatory bowel disease index, i-NOS, NO, MDA, and COX-2 in colon tissues and TNF-α, MPO, and IL-1β in blood serums, were decreased in the treatment group as compared to the model group. The gene discussed is IL1B; the disease is inflammatory bowel disease.